| Literature DB >> 31179723 |
Hong Li1, Ling Tan2,3, Jia-Wei Zhang3, Hong Chen1, Bing Liang1, Ting Qiu1, Qing-Song Li1, Min Cai1, Qi-Hui Zhang3.
Abstract
Yang-Yin-Qing-Fei-Tang (YYQFT) is a well-known traditional Chinese medicine used in the treatment of chronic obstructive pulmonary emphysema, bronchitis, cytomegaloviral pneumonia, but the mechanisms of the medicine are not clear. This study aimed to identify the active components of YYQFT and elucidate the underlying mechanism on non-small cell lung cancer. First, YYQFT was extracted with different solvents, and then the most effective extract was determined by assessing their effects on non-small cell lung cancer cell growth. Second, several active compounds from YYQFT were identified, and quercetin was the one of the important active ingredients. Subsequently, the in vivo antitumor activity of quercetin was confirmed in a lung cancer xenograft model in mice. 200 μ g/mL quercetin significantly reduced tumor volume without affecting body weight of the mice. Furthermore, induction of apoptosis by quercetin was detected in tumor tissues treated with quercetin. Multiple apoptosis related genes including p53, Bax and Fas were upregulated by quercetin in tumor tissue and the ratio of Bax/Bcl-2 was increased accordingly. Our results demonstrated that quercetin, as the main effective component of the YYQFT, has potent inhibitory activity on non-small cell lung cancer by regulating the ratio of Bax/Bcl-2.Entities:
Keywords: Apoptosis; Bax/Bcl-2; Lung Cancer; Quercetin; Yang-Yin-Qing-Fei-Tang
Mesh:
Substances:
Year: 2019 PMID: 31179723 DOI: 10.1142/S0192415X19500460
Source DB: PubMed Journal: Am J Chin Med ISSN: 0192-415X Impact factor: 4.667